The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan

Archives of Pharmacal Research

Volumn 35, Issue 5, 2012, Pages 937-943

  Song, Keon Hyoung ^a,b   Eddington, Natalie D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b Seoul National University   (South Korea)

Author keywords

Antiretroviral drug; AT1002; Bioadhesive polymer; Carrageenan; Permeation enhancer; Ritonavir

Indexed keywords

AT1002; CARRAGEENAN; PEPTIDE FRAGMENT; RITONAVIR; TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BIOLOGICAL ACTIVITY; CELL JUNCTION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; MALE; MOLECULAR WEIGHT; NONHUMAN; PROTEIN TRANSPORT; RAT;

ADMINISTRATION, INTRANASAL; ANIMALS; CARRAGEENAN; DRUG DELIVERY SYSTEMS; MALE; OLIGOPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RITONAVIR; TISSUE ADHESIVES;

EID: 84862849245     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0520-1     Document Type: Article

References (26)

1. Aijaz, S., Balda, M. S., and Matter, K., Tight junctions: molecular architecture and function. Int. Rev. Cytol., 248, 261-298 (2006).
2. Andras, I. E., Pu, H., Deli, M. A., Nath, A., Hennig, B., and Toborek, M., HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J. Neurosci. Res., 74, 255-265 (2003).
3. Beatch, M., Jesaitis, L. A., Gallin, W. J., Goodenough, D. A., and Stevenson, B. R., The tight junction protein ZO-2 contains three PDZ (PSD-95/Discs-Large/ZO-1) domains and an alternatively spliced region. J. Biol. Chem., 271, 25723-25726 (1996).
4. Collins, J. R. and Rizzolo, L. J., Protein-binding domains of the tight junction protein, ZO-2, are highly conserved between avian and mammalian species. Biochem. Biophys. Res. Commun., 252, 617-622 (1998).
5. Cox, D. S., Gao, H., Raje, S., Scott, K. R., and Eddington, N. D., Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin. Eur. J. Pharm. Biopharm., 52, 145-150 (2001).
6. Cox, D. S., Raje, S., Gao, H., Salama, N. N., and Eddington, N. D., Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin. Pharm. Res., 19, 1680-1688 (2002).
7. Di Pierro, M., Lu, R., Uzzau, S., Wang, W., Margaretten, K., Pazzani, C., Maimone, F., and Fasano, A., Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J. Biol. Chem., 276, 19160-19165 (2001).
8. Fasano, A., Fiorentini, C., Donelli, G., Uzzau, S., Kaper, J. B., Margaretten, K., Ding, X., Guandalini, S., Comstock, L., and Goldblum, S. E., Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J. Clin. Invest., 96, 710-720 (1995).
9. Fasano, A. and Uzzau, S., Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest., 99, 1158-1164 (1997).
10. Fasano, A., Uzzau, S., Fiore, C., and Margaretten, K., The enterotoxic effect of zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology, 112, 839-846 (1997).
11. Gonzalez-Mariscal, L., Islas, S., Contreras, R. G., Garcia-Villegas, M. R., Betanzos, A., Vega, J., Diaz-Quinonez, A., Martin-Orozco, N., Ortiz-Navarrete, V., Cereijido, M., and Valdes, J., Molecular characterization of the tight junction protein ZO-1 in MDCK cells. Exp. Cell Res., 248, 97-109 (1999).
12. Gonzalez-Mariscal, L., Betanzos, A., and Avila-Flores, A., MAGUK proteins: structure and role in the tight junction. Semin. Cell Dev. Biol., 11, 315-324 (2000).
13. Gopalakrishnan, S., Pandey, N., Tamiz, A. P., Vere, J., Carrasco, R., Somerville, R., Tripathi, A., Ginski, M., Paterson, B. M., and Alkan, S. S., Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. Int. J. Pharm., 365, 121-130 (2009).
14. Johnson, P. H. and Quay, S. C., Advances in nasal drug delivery through tight junction technology. Expert Opin. Drug Deliv., 2, 281-298 (2005).
15. Karyekar, C. S., Fasano, A., Raje, S., Lu, R., Dowling, T. C., and Eddington, N. D., Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. J. Pharm. Sci., 92, 414-423 (2003).
16. Kondoh, M., Masuyama, A., Takahashi, A., Asano, N., Mizuguchi, H., Koizumi, N., Fujii, M., Hayakawa, T., Horiguchi, Y., and Watanbe, Y., A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol., 67, 749-756 (2005).
17. Kuboyama, Y., Mori, K., Suzuki, K., Ishii, A., and Shuto, K., Changes in nasal cavity volume and target area of exposure to nasal drops with age in rats. Exp. Anim., 45, 15-22 (1996).
18. Larson, J., Schomberg, S., Schroeder, W., and Carpenter, T. C., Endothelial EphA receptor stimulation increases lung vascular permeability. Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L431-L439 (2008).
19. Salama, N. N., Fasano, A., Lu, R., and Eddington, N. D., Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol. Int. J. Pharm., 251, 113-121 (2003).
20. Salama, N. N., Fasano, A., Thakar, M., and Eddington, N. D., The effect of delta G on the transport and oral absorption of macromolecules. J. Pharm. Sci., 93, 1310-1319 (2004).
21. Salama, N. N., Fasano, A., Thakar, M., and Eddington, N. D., The impact of DeltaG on the oral bioavailability of low bioavailable therapeutic agents. J. Pharmacol. Exp. Ther., 312, 199-205 (2005).
22. Sharp, P. E. and La Regina, M. C., The Laboratory Rat. CRC Press, Boca Raton, FL, (1998).
23. Song, K. H., Fasano, A., and Eddington, N. D., Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int. J. Pharm., 351, 8-14 (2008a).
24. Song, K. H., Fasano, A., and Eddington, N. D., Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator. Eur. J. Pharm. Biopharm., 69, 231-237 (2008b).
25. Song, K. H. and Eddington, N. D., The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001. J. Pharm. Pharmacol., 64, 30-39 (2012a).
26. Song, K. H. and Eddington, N. D., The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker. Arch. Pharm. Res., 35, 359-366 (2012b).